의료진 소개 내용
장석준 교수는 1995년 아주대 의과대학을 졸업하고 아주대병원 산부인과 연구강사 및 서울아산병원 산부인과 임상강사를 거쳐 현재 아주대 의과대학 산부인과 교수로 근무하며 아주대병원 암센터장과 수술실장을 맡고있다.전문진료분야는 부인암(난소암, 자궁경부암, 자궁내막암, 임신융모암, 외음부암), 복강경수술, 부인과(자궁근종, 선근증, 난소종양), 비뇨부인과(요실금, 자궁탈출증)로, 장석준 교수는 자궁근종 및 양성 난소종양뿐만 아니라 자궁내막암, 자궁경부암 등의 부인암 환자에서 복강경 수술을 시행하여 통증을 최소화하고 입원기간을 단축시키는 동시에 높은 생존율을 유지하는 좋은 결과를 보이고 있다.
또한 장석준 교수는 난소암 수술 분야에서 좋은 성적을 보이고 있는 미국 얼바인 캘리포니아대학교 부인암 센터에서 1년간 난소암의 근치수술에 대한 장기 연수를 하였고 뛰어난 연구 성과를 보여 학계와 언론의 큰 주목을 받고 있다.
대외적으로 대한산부인과학회, 대한부인종양학회, 대한산부인과내시경학회, 대한비뇨부인학회에서 활발히 활동하고 있다.
주요경력 내용
-
약력
- 아주대 의과대학 졸업
- 아주대병원 산부인과 부인종양 분과 연구강사
- 서울아산병원 산부인과 부인종양 분과 임상강사
- 미국 얼바인 캘리포니아대 메디컬센터 부인암센터 연수
- 아주대병원 부인암센터장 역임
- 아주대병원 교육수련부장 역임
- 아주대 의과대학 산부인과 교수
- 아주대병원 암센터장
- 아주대병원 수술실장
-
경력
- 1995 아주대 의과대학 졸업, 산부인과 전문의
- 2004 ~ 2005 아주대병원 산부인과 부인종양 분과 연구강사
- 2005 ~ 2006 서울아산병원 산부인과 부인종양 분과 임상강사
- 2011 ~ 2012 미국 얼바인 캘리포니아대학교 메디컬센터 부인암센터 연수
- 2014 ~ 2020 아주대병원 부인암센터장
- 2020 아주대병원 교육수련부장
- 2006 ~ 현재 아주대 의과대학 산부인과 조교수, 부교수, 교수
- 2022 ~ 현재 아주대병원 암센터장
- 2022 ~ 현재 아주대병원 수술실장
논문 내용
-
- Chang SJ, Bristow RE, Ryu HS. Analysis of para-aortic lymphadenectomy up to the level of the renal vessels in apparent early-stage ovarian cancer. J Gynecol Oncol. 2013 Jan;24(1):29-36
- Chang SJ, Bristow RE, Ryu HS. Impact of Complete Cytoreduction Leaving No Gross Residual Disease Associated with Radical Cytoreductive Surgical Procedures on Survival in Advanced Ovarian Cancer. Ann Surg Oncol. 2012;19(13):4059-67.
- Kong TW, Chang SJ, Paek J, Yoo SC, Yoon JH, Chang KH, Chun M, Ryu HS. Comparison of concurrent chemoradiation therapy with weekly cisplatin versus monthly fluorouracil plus cisplatin in FIGO stage IIB-IVA cervical cancer. J Gynecol Oncol. 2012;23(4):235-41.
- Chang SJ, Bristow RE, Ryu HS. Prognostic significance of systematic lymphadenectomy as part of primary debulking surgery in patients with advanced ovarian cancer. Gynecol Oncol. 2012 Sep;126(3):381-6.
- Kong TW, Paek J, Chang SJ, Chun M, Chang KH, Ryu HS. Comprehensive staging surgery including complete pelvic and para-aortic lymphadenectomy followed by adjuvant vaginal brachytherapy improves survival rates for intermediate-risk endometrial cancer patients. Gynecol Obstet Invest. 2012;74(1):68-75.
- Chang SJ, Ryu HS, Nam JH. Uterine artery-preserving laparoscopic radical trachelectomy for early cervical cancer: technical aspects. Gynecol Oncol. 2012 Aug;126(2):277-8.
- Chang SJ, Ryu HS. Laparoscopic para-aortic lymphadenectomy in endometrial cancer patient with left-sided inferior vena cava. Gynecol Oncol. 2012 Jul;126(1):147-8.
- Chang SJ, Bristow RE, Ryu HS. A model for prediction of parametrial involvement and feasibility of less radical resection of parametrium in patients with FIGO stage IB1 cervical cancer. Gynecol Oncol. 2012 Jul;126(1):82-6.
- Chang SJ, Bristow RE. Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: redefining 'optimal' residual disease. Gynecol Oncol. 2012 May;125(2):483-92.
- Kim HS, Choi CH, Lim MC, Chang SJ, Kim YB, Kim MA, Kim TJ, Park SY, Kim BG, Song YS, Bae DS, Kim JW. Safe criteria for less radical trachelectomy in patients with early-stage cervical cancer: a multicenter clinicopathologic study. Ann Surg Oncol. 2012 Jun;19(6):1973-9.
- Hong WS, Kim KS, Jung YS, Kang SY, Kang DK, Kim TH, Yim H, Chun M, Park MC, Chang SJ. Risk Reducing Surgery in Carriers with Double Heterozygosity for BRCA1 and BRCA2 Mutations. J Genet Med. 2012 Jun;9(1):25-30.
- Kim WY, Chang SJ, Chang KH, Yoo SC, Lee EJ, Ryu HS. Reliability of magnetic resonance imaging for bladder or rectum invasion in cervical cancer. J Reprod Med. 2011 Nov-Dec;56(11-12):485-90.
- Kim WY, Chang SJ, Chang KH, Yoo SC, Chun M, Ryu HS. Treatment patterns and outcomes in bulky stage IB2 cervical cancer patients: a single institution's experience over 14 years. Gynecol Obstet Invest. 2011;71(1):19-23.
- Chang SJ, Kong TW, Kim WY, Yoo SC, Yoon JH, Chang KH, Ryu HS. Lymph-vascular space invasion as a significant risk factor for isolated para-aortic lymph node metastasis in endometrial cancer: a study of 203 consecutive patients. Ann Surg Oncol. 2011 Jan;18(1):58-64.
- Kong TW, Kim JH, Chang SJ, Chang KH, Ryu HS, Joo HJ. Sarcomatoid squamous cell carcinoma of the uterine cervix successfully treated by laparoscopic radical hysterectomy: a case report. J Reprod Med. 2010 Sep-Oct;55(9-10):445-8.
- Yoon JH, Yoo SC, Kim WY, Chang SJ, Chang KH, Ryu HS. Para-aortic lymphadenectomy in the management of preoperative grade 1 endometrial cancer confined to the uterine corpus. Ann Surg Oncol. 2010 Dec;17(12):3234-40.
- Kong TW, Lee KM, Cheong JY, Kim WY, Chang SJ, Yoo SC, Yoon JH, Chang KH, Ryu HS. Comparison of laparoscopic versus conventional open surgical staging procedure for endometrial cancer. J Gynecol Oncol. 2010;21(2):106-11.
- Chang SJ, Lee EJ, Kim WY, Yoo SC, Yoon JH, Chang KH, Ryu HS. The Value of Sonohysterography in Preoperative Assessment of Myometrial Invasion for Patients with Endometrial Cancer J Ultrasound Med. 2010;29(6):923-9.
- Kim H, Choi DS, Chang SJ, Han JH, Min CK, Chang KH, Ryu HS. The expression of syndecan-1 is related to the risk of endometrial hyperplasia progressing to endometrial carcinoma. J Gynecol Oncol. 2010;21(1):50-5.
- Kim WY, Chang SJ, Chang KH, Yoo SC, Ryu HS. Conservative management of stage IA1 squamous cell carcinoma of the cervix with positive resection margins after conization. Int J Gynaecol Obstet. 2010;109(2):110-2.
- Yoo SC, Kim WY, Yoon JH, Chang SJ, Chang KH, Ryu HS. Young girls with malignant ovarian germ cell tumors can undergo normal menarche and menstruation after fertility-preserving surgery and adjuvant chemotherapy. Acta Obstet Gynecol Scand. 2010;89(1):126-30.
- Chang SJ, Kim WY, Yoo SC, Yoon JH, Chun M, Chang KH, Ryu HS. A validation study of new risk grouping criteria for postoperative treatment in stage IB cervical cancers without high-risk factors: rethinking the Gynecologic Oncology Group criteria. Eur J Obstet Gynecol Reprod Biol. 2009;147(1):91-6.
- Yoon JH, Yoo SC, Kim WY, Chang SJ, Chang KH, Ryu HS. Role of HPV DNA testing for detection of high-grade cervical lesions in women with atypical squamous cells of undetermined significance: A prospective study in a Korean population. Eur J Gynaecol Oncol. 2009;30(3):271-74.
- Yoo SC, Kim WY, Yoon JH, Kim HY, Lee EJ, Chang SJ, Chang KH, Ryu HS. Accuracy of preoperative magnetic resonance imaging in assessing lymph node metastasis and myometrial invasion in patients with uterine cancer. Eur J Gynaecol Oncol. 2009;30(2):167-70.
- Yoo SC, Yoon JH, Kim WY, Chang SJ, Joo HJ, Chang KH, Ryu HS. Premenopausal early-stage endometrial carcinoma patients with low CA-125 levels and low tumor grade may undergo ovary-saving surgery. J Gynecol Oncol. 2009;20(3):181-6.
- Byun YJ, Kim HS, Yang JI, Kim JH, Kim HY, Chang SJ. Umbilical artery Doppler study as a predictive marker of perinatal outcome in preterm small for gestational age infants. Yonsei Med J. 2009;50(1):39-44.
- Kim WY, Chang SJ, Chang KH, Yoon JH, Kim JH, Kim BG, Bae DS, Ryu HS. Uterine Leiomyosarcoma : 14-year Two-center Experience of 31 Cases. Cancer Res Treat. 2009;41(1):24-28.
- Chang SJ, Ryu HS, Chang KH, Yoo SC, Yoon JH. Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors. Acta Obstet Gynecol Scand. 2008;87(4):476-81.
- Yoo SC, Yoon JH, Lyu MO, Kim WY, Chang SJ, Chang KH, Ryu HS. Significance of postoperative CA-125 decline after cytoreductive surgery in stage IIIC/IV ovarian cancer. J Gynecol Oncol. 2008;19(3):169-72.
- Kim WY, Chang SJ, Chang KH, Yoo SC, Chun M, Ryu HS. Differing prognosis of cervical cancer patients with high risk of treatment failure after radical hysterectomy warrants trial treatment modification. J Gynecol Oncol. 2009;20(1):17-21.
- Yoo SC, Chang KH, Lyu MO, Chang SJ, Ryu HS, Kim HS. Clinical characteristics of struma ovarii. J Gynecol Oncol. 2008;19(2):135-138.
- Kim YM, Park JY, Lee KM, Kong TW, Yoo SC, Kim WY, Yoon JH, Chang SJ, Chang KH, Ryu HS. Does pretreatment HPV viral load correlate with prognosis in patients with early stage cervical carcinoma? J Gynecol Oncol. 2008;19(2):113-116.
- Chang SJ, Kim WY, Yoon JH, Yoo SC, Chang KH, Ryu HS. Para-aortic lymphadenectomy improves survival in patients with intermediate to high-risk endometrial carcinoma. Acta Obstet Gynecol Scand. 2008;87(12):1361-9.
- Chang KH, Ryu HS, Chang SJ, Byun YJ, Lee JP. Relationship between Pre-treatment Serum SCC (squamous cell carcinoma) Antigen, Cyfra 21-1 Levels, and Survival in Squamous Cell Carcinoma of the Uterine Cervix. Cancer Res Treat. 2005;37(5):302-306.
- Ryu HS, Chang KH, Chang SJ, Kim MS, Joo HJ, Oh KS. Expression of TRAIL (TNF-related apoptosis-inducing ligand) receptors in cervical cancer. Int J Gynecol Cancer. 2000;10(5):417-424.
언론보도 내용
장석준 교수는 1995년 아주대 의과대학을 졸업하고 아주대병원 산부인과 연구강사 및 서울아산병원 산부인과 임상강사를 거쳐 현재 아주대 의과대학 산부인과 교수로 근무하며 아주대병원 암센터장과 수술실장을 맡고있다.
전문진료분야는 부인암(난소암, 자궁경부암, 자궁내막암, 임신융모암, 외음부암), 복강경수술, 부인과(자궁근종, 선근증, 난소종양), 비뇨부인과(요실금, 자궁탈출증)로, 장석준 교수는 자궁근종 및 양성 난소종양뿐만 아니라 자궁내막암, 자궁경부암 등의 부인암 환자에서 복강경 수술을 시행하여 통증을 최소화하고 입원기간을 단축시키는 동시에 높은 생존율을 유지하는 좋은 결과를 보이고 있다.
또한 장석준 교수는 난소암 수술 분야에서 좋은 성적을 보이고 있는 미국 얼바인 캘리포니아대학교 부인암 센터에서 1년간 난소암의 근치수술에 대한 장기 연수를 하였고 뛰어난 연구 성과를 보여 학계와 언론의 큰 주목을 받고 있다.
대외적으로 대한산부인과학회, 대한부인종양학회, 대한산부인과내시경학회, 대한비뇨부인학회에서 활발히 활동하고 있다.
전문진료분야는 부인암(난소암, 자궁경부암, 자궁내막암, 임신융모암, 외음부암), 복강경수술, 부인과(자궁근종, 선근증, 난소종양), 비뇨부인과(요실금, 자궁탈출증)로, 장석준 교수는 자궁근종 및 양성 난소종양뿐만 아니라 자궁내막암, 자궁경부암 등의 부인암 환자에서 복강경 수술을 시행하여 통증을 최소화하고 입원기간을 단축시키는 동시에 높은 생존율을 유지하는 좋은 결과를 보이고 있다.
또한 장석준 교수는 난소암 수술 분야에서 좋은 성적을 보이고 있는 미국 얼바인 캘리포니아대학교 부인암 센터에서 1년간 난소암의 근치수술에 대한 장기 연수를 하였고 뛰어난 연구 성과를 보여 학계와 언론의 큰 주목을 받고 있다.
대외적으로 대한산부인과학회, 대한부인종양학회, 대한산부인과내시경학회, 대한비뇨부인학회에서 활발히 활동하고 있다.
-
약력
- 아주대 의과대학 졸업
- 아주대병원 산부인과 부인종양 분과 연구강사
- 서울아산병원 산부인과 부인종양 분과 임상강사
- 미국 얼바인 캘리포니아대 메디컬센터 부인암센터 연수
- 아주대병원 부인암센터장 역임
- 아주대병원 교육수련부장 역임
- 아주대 의과대학 산부인과 교수
- 아주대병원 암센터장
- 아주대병원 수술실장
-
경력
- 1995 아주대 의과대학 졸업, 산부인과 전문의
- 2004 ~ 2005 아주대병원 산부인과 부인종양 분과 연구강사
- 2005 ~ 2006 서울아산병원 산부인과 부인종양 분과 임상강사
- 2011 ~ 2012 미국 얼바인 캘리포니아대학교 메디컬센터 부인암센터 연수
- 2014 ~ 2020 아주대병원 부인암센터장
- 2020 아주대병원 교육수련부장
- 2006 ~ 현재 아주대 의과대학 산부인과 조교수, 부교수, 교수
- 2022 ~ 현재 아주대병원 암센터장
- 2022 ~ 현재 아주대병원 수술실장
-
- Chang SJ, Bristow RE, Ryu HS. Analysis of para-aortic lymphadenectomy up to the level of the renal vessels in apparent early-stage ovarian cancer. J Gynecol Oncol. 2013 Jan;24(1):29-36
- Chang SJ, Bristow RE, Ryu HS. Impact of Complete Cytoreduction Leaving No Gross Residual Disease Associated with Radical Cytoreductive Surgical Procedures on Survival in Advanced Ovarian Cancer. Ann Surg Oncol. 2012;19(13):4059-67.
- Kong TW, Chang SJ, Paek J, Yoo SC, Yoon JH, Chang KH, Chun M, Ryu HS. Comparison of concurrent chemoradiation therapy with weekly cisplatin versus monthly fluorouracil plus cisplatin in FIGO stage IIB-IVA cervical cancer. J Gynecol Oncol. 2012;23(4):235-41.
- Chang SJ, Bristow RE, Ryu HS. Prognostic significance of systematic lymphadenectomy as part of primary debulking surgery in patients with advanced ovarian cancer. Gynecol Oncol. 2012 Sep;126(3):381-6.
- Kong TW, Paek J, Chang SJ, Chun M, Chang KH, Ryu HS. Comprehensive staging surgery including complete pelvic and para-aortic lymphadenectomy followed by adjuvant vaginal brachytherapy improves survival rates for intermediate-risk endometrial cancer patients. Gynecol Obstet Invest. 2012;74(1):68-75.
- Chang SJ, Ryu HS, Nam JH. Uterine artery-preserving laparoscopic radical trachelectomy for early cervical cancer: technical aspects. Gynecol Oncol. 2012 Aug;126(2):277-8.
- Chang SJ, Ryu HS. Laparoscopic para-aortic lymphadenectomy in endometrial cancer patient with left-sided inferior vena cava. Gynecol Oncol. 2012 Jul;126(1):147-8.
- Chang SJ, Bristow RE, Ryu HS. A model for prediction of parametrial involvement and feasibility of less radical resection of parametrium in patients with FIGO stage IB1 cervical cancer. Gynecol Oncol. 2012 Jul;126(1):82-6.
- Chang SJ, Bristow RE. Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: redefining 'optimal' residual disease. Gynecol Oncol. 2012 May;125(2):483-92.
- Kim HS, Choi CH, Lim MC, Chang SJ, Kim YB, Kim MA, Kim TJ, Park SY, Kim BG, Song YS, Bae DS, Kim JW. Safe criteria for less radical trachelectomy in patients with early-stage cervical cancer: a multicenter clinicopathologic study. Ann Surg Oncol. 2012 Jun;19(6):1973-9.
- Hong WS, Kim KS, Jung YS, Kang SY, Kang DK, Kim TH, Yim H, Chun M, Park MC, Chang SJ. Risk Reducing Surgery in Carriers with Double Heterozygosity for BRCA1 and BRCA2 Mutations. J Genet Med. 2012 Jun;9(1):25-30.
- Kim WY, Chang SJ, Chang KH, Yoo SC, Lee EJ, Ryu HS. Reliability of magnetic resonance imaging for bladder or rectum invasion in cervical cancer. J Reprod Med. 2011 Nov-Dec;56(11-12):485-90.
- Kim WY, Chang SJ, Chang KH, Yoo SC, Chun M, Ryu HS. Treatment patterns and outcomes in bulky stage IB2 cervical cancer patients: a single institution's experience over 14 years. Gynecol Obstet Invest. 2011;71(1):19-23.
- Chang SJ, Kong TW, Kim WY, Yoo SC, Yoon JH, Chang KH, Ryu HS. Lymph-vascular space invasion as a significant risk factor for isolated para-aortic lymph node metastasis in endometrial cancer: a study of 203 consecutive patients. Ann Surg Oncol. 2011 Jan;18(1):58-64.
- Kong TW, Kim JH, Chang SJ, Chang KH, Ryu HS, Joo HJ. Sarcomatoid squamous cell carcinoma of the uterine cervix successfully treated by laparoscopic radical hysterectomy: a case report. J Reprod Med. 2010 Sep-Oct;55(9-10):445-8.
- Yoon JH, Yoo SC, Kim WY, Chang SJ, Chang KH, Ryu HS. Para-aortic lymphadenectomy in the management of preoperative grade 1 endometrial cancer confined to the uterine corpus. Ann Surg Oncol. 2010 Dec;17(12):3234-40.
- Kong TW, Lee KM, Cheong JY, Kim WY, Chang SJ, Yoo SC, Yoon JH, Chang KH, Ryu HS. Comparison of laparoscopic versus conventional open surgical staging procedure for endometrial cancer. J Gynecol Oncol. 2010;21(2):106-11.
- Chang SJ, Lee EJ, Kim WY, Yoo SC, Yoon JH, Chang KH, Ryu HS. The Value of Sonohysterography in Preoperative Assessment of Myometrial Invasion for Patients with Endometrial Cancer J Ultrasound Med. 2010;29(6):923-9.
- Kim H, Choi DS, Chang SJ, Han JH, Min CK, Chang KH, Ryu HS. The expression of syndecan-1 is related to the risk of endometrial hyperplasia progressing to endometrial carcinoma. J Gynecol Oncol. 2010;21(1):50-5.
- Kim WY, Chang SJ, Chang KH, Yoo SC, Ryu HS. Conservative management of stage IA1 squamous cell carcinoma of the cervix with positive resection margins after conization. Int J Gynaecol Obstet. 2010;109(2):110-2.
- Yoo SC, Kim WY, Yoon JH, Chang SJ, Chang KH, Ryu HS. Young girls with malignant ovarian germ cell tumors can undergo normal menarche and menstruation after fertility-preserving surgery and adjuvant chemotherapy. Acta Obstet Gynecol Scand. 2010;89(1):126-30.
- Chang SJ, Kim WY, Yoo SC, Yoon JH, Chun M, Chang KH, Ryu HS. A validation study of new risk grouping criteria for postoperative treatment in stage IB cervical cancers without high-risk factors: rethinking the Gynecologic Oncology Group criteria. Eur J Obstet Gynecol Reprod Biol. 2009;147(1):91-6.
- Yoon JH, Yoo SC, Kim WY, Chang SJ, Chang KH, Ryu HS. Role of HPV DNA testing for detection of high-grade cervical lesions in women with atypical squamous cells of undetermined significance: A prospective study in a Korean population. Eur J Gynaecol Oncol. 2009;30(3):271-74.
- Yoo SC, Kim WY, Yoon JH, Kim HY, Lee EJ, Chang SJ, Chang KH, Ryu HS. Accuracy of preoperative magnetic resonance imaging in assessing lymph node metastasis and myometrial invasion in patients with uterine cancer. Eur J Gynaecol Oncol. 2009;30(2):167-70.
- Yoo SC, Yoon JH, Kim WY, Chang SJ, Joo HJ, Chang KH, Ryu HS. Premenopausal early-stage endometrial carcinoma patients with low CA-125 levels and low tumor grade may undergo ovary-saving surgery. J Gynecol Oncol. 2009;20(3):181-6.
- Byun YJ, Kim HS, Yang JI, Kim JH, Kim HY, Chang SJ. Umbilical artery Doppler study as a predictive marker of perinatal outcome in preterm small for gestational age infants. Yonsei Med J. 2009;50(1):39-44.
- Kim WY, Chang SJ, Chang KH, Yoon JH, Kim JH, Kim BG, Bae DS, Ryu HS. Uterine Leiomyosarcoma : 14-year Two-center Experience of 31 Cases. Cancer Res Treat. 2009;41(1):24-28.
- Chang SJ, Ryu HS, Chang KH, Yoo SC, Yoon JH. Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors. Acta Obstet Gynecol Scand. 2008;87(4):476-81.
- Yoo SC, Yoon JH, Lyu MO, Kim WY, Chang SJ, Chang KH, Ryu HS. Significance of postoperative CA-125 decline after cytoreductive surgery in stage IIIC/IV ovarian cancer. J Gynecol Oncol. 2008;19(3):169-72.
- Kim WY, Chang SJ, Chang KH, Yoo SC, Chun M, Ryu HS. Differing prognosis of cervical cancer patients with high risk of treatment failure after radical hysterectomy warrants trial treatment modification. J Gynecol Oncol. 2009;20(1):17-21.
- Yoo SC, Chang KH, Lyu MO, Chang SJ, Ryu HS, Kim HS. Clinical characteristics of struma ovarii. J Gynecol Oncol. 2008;19(2):135-138.
- Kim YM, Park JY, Lee KM, Kong TW, Yoo SC, Kim WY, Yoon JH, Chang SJ, Chang KH, Ryu HS. Does pretreatment HPV viral load correlate with prognosis in patients with early stage cervical carcinoma? J Gynecol Oncol. 2008;19(2):113-116.
- Chang SJ, Kim WY, Yoon JH, Yoo SC, Chang KH, Ryu HS. Para-aortic lymphadenectomy improves survival in patients with intermediate to high-risk endometrial carcinoma. Acta Obstet Gynecol Scand. 2008;87(12):1361-9.
- Chang KH, Ryu HS, Chang SJ, Byun YJ, Lee JP. Relationship between Pre-treatment Serum SCC (squamous cell carcinoma) Antigen, Cyfra 21-1 Levels, and Survival in Squamous Cell Carcinoma of the Uterine Cervix. Cancer Res Treat. 2005;37(5):302-306.
- Ryu HS, Chang KH, Chang SJ, Kim MS, Joo HJ, Oh KS. Expression of TRAIL (TNF-related apoptosis-inducing ligand) receptors in cervical cancer. Int J Gynecol Cancer. 2000;10(5):417-424.
-
- 출처EBS 명의
- 등록일2024-09-27
- 포기하기엔 이르다 - 복막암
-
- 출처경기신문
- 등록일2023-12-19
- 장석준 교수, 아시아 부인종양 연구 ‘앞장’
-
- 출처국민일보
- 등록일2023-09-12
- 항암제 데워 복강에… 난소암 사망 위험 70% 줄어
-
- 출처중앙일보
- 등록일2023-09-08
- 하이펙 치료로 진행성 난소암 환자 생존기간 9개월 늘려
-
- 출처중앙일보
- 등록일2023-05-18
- 첫 환자 떠난 뒤 “일도입혼”... ‘난소암 킬러’ 되다
-
- 출처헬스경향
- 등록일2022-10-25
- 아주대병원 장석준 교수, ‘난소암·복막암 종양감축수술 워크숍’ 튜터 참석
-
- 출처중앙일보
- 등록일2022-10-18
- 진행성 난소암에 온열 치료했더니 사망 위험 70% 감소
-
- 출처헬스경향
- 등록일2022-10-13
- 아주대병원 장석준 교수, 국제부인암학회 차기 학술위원장 선출
-
- 출처동아일보
- 등록일2022-08-10
- “재발-전이 많은 난소암, 소화불량으로 오인해 진단 늦어져”
-
- 출처동아일보
- 등록일2022-07-27
- 초기발견 어려운 난소암… 치료 후 생존기간 연장해 줄 명의는
-
- 출처헬스조선
- 등록일2021-04-19
- ‘Gyencologic Oncology’ 특별판 편집인 위촉
-
- 출처중앙일보
- 등록일2020-03-23
- BRCA 변이와 상관없이 쓰는 난소암 치료제
-
- 출처KBS 생로병사의 비밀
- 등록일2019-06-05
- 중심을 잡아야 바로 선다, 고관절과 골반
-
- 출처경향신문
- 등록일2019-03-28
- 난소암 재발률 80%를 생존율로 바꿔드립니다
-
- 출처중앙일보
- 등록일2018-11-26
- 부인암센터 ‘두 번 고통은 없다’ 세계 기준 능가한 치료 성적 견인차
-
- 출처TV조선 슈퍼푸드의비밀 천년만년
- 등록일2017-02-19
- 10년 째 투병 중인 여성, 7개 장기를 잃은 이유는?
-
- 출처국민일보
- 등록일2016-04-05
- 명의·인의를 찾아서-아주대학교병원 부인암센터